References
- WollinaUMachetanzJHerpes zoster und postzosterische NeuralgieHautarzt201667865366527389412
- HornsteinOPDifferentialdiagnose der GesichtsschwellungenHNO1979274129137374316
- WernerRNNikkelsAFMarinovićBEuropean consensus-based (S2k) Guideline on the Management of Herpes Zoster – guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 1: diagnosisJ Eur Acad Dermatol Venereol201731191927804172
- WernerRNNikkelsAFMarinovićBEuropean consensus-based (S2k) Guideline on the Management of Herpes Zoster – guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 2: treatmentJ Eur Acad Dermatol Venereol2017311202927579792
- TitmarshGJMcMullinMFMcShaneCMClarkeMEngelsEAAndersonLACommunity-acquired infections and their association with myeloid malignanciesCancer Epidemiol2014381566124275260
- BennettJMChanges in the updated 2016: WHO classification of the myelodysplastic syndromes and related myeloid neoplasmsClin Lymphoma Myeloma Leuk2016161160760927693133
- DiNardoCDGarcia-ManeroGPierceSInteractions and relevance of blast percentage and treatment strategy among younger and older patients with acute myeloid leukemia (AML) and myelodysplastic syndromeAm J Hematol201691222723226799610
- BrecciaMLatagliataRCannellaLAnalysis of prognostic factors in patients with refractory anemia with excess of blasts (RAEB) reclassified according to WHO proposalLeuk Res200933339139418676015
- GuptaMAshok KumarJSitaramUThe t(6;9)(p22;q34) in myeloid neoplasms: a retrospective study of 16 casesCancer Genet Cytogenet2010203229730221156248